Viveve Announces Topline Results from Pivotal U.S. PURSUIT Trial for Treating Female Stress Urinary Incontinence
Study’s most important efficacy endpoint was not obtained at 12 months post-treatment methodFirm has implemented
Viveve
Study’s most important efficacy endpoint was not obtained at 12 months post-treatment methodFirm has implemented